These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37891349)

  • 1. A new non-human primate model of familial hypercholesterolemia.
    Ferreira J
    Lab Anim (NY); 2023 Nov; 52(11):266. PubMed ID: 37891349
    [No Abstract]   [Full Text] [Related]  

  • 2. Generation of a familial hypercholesterolemia model in non-human primate.
    Sato A; Tsukiyama T; Komeno M; Iwatani C; Tsuchiya H; Kawamoto I; Murase M; Nakagawa T; Itagaki I; Seita Y; Matsumoto S; Nakaya M; Shimizu A; Yamada A; Ema M; Ogita H
    Sci Rep; 2023 Sep; 13(1):15649. PubMed ID: 37730951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [FAMILIAL XANTHOMATOUS HYPERCHOLESTEROLEMIA. BIOCLINICAL AND THERAPEUTIC STUDY].
    LEURIDAN B
    J Sci Med Lille; 1965 Feb; 83():137-8. PubMed ID: 14308373
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia.
    Geiss HC; Schwandt P; Parhofer KG
    Exp Clin Endocrinol Diabetes; 2002 Jun; 110(4):182-7. PubMed ID: 12058342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Towards gene therapy in familial hypercholesterolemia].
    Pagès JC; Andreoletti M; Loux N; Vons C; Mahieu D; Bargy F; Chapman J; Briand P; Franco D; Weber A
    C R Seances Soc Biol Fil; 1996; 190(1):53-65. PubMed ID: 8881269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in ultracentrifugally separated plasma lipoprotein subfractions in patients with polygenic hypercholesterolemia, familial combined hyperlipoproteinemia, and familial hypercholesterolemia after treatment with atorvastatin.
    Homma K; Homma Y; Yoshida T; Ozawa H; Shiina Y; Wakino S; Hayashi K; Itoh H; Hori S
    J Clin Lipidol; 2015; 9(2):210-6. PubMed ID: 25911077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polygenic Risk Scores in Familial Hypercholesterolemia.
    Rader DJ; Sheth S
    J Am Coll Cardiol; 2019 Jul; 74(4):523-525. PubMed ID: 31345426
    [No Abstract]   [Full Text] [Related]  

  • 8. [The diagnostic value of measurement of Achilles tendon thickness by skin fold caliper for discrimination of familial hypercholesterolemia and non-familial hypercholesterolemia (author's transl)].
    Ueda K; Yoshimura A; Watanabe A; Wakasugi T; Tadami R; Ueda R; Kametani T; Haba T; Ito S; Koizumi J; Ohota M; Miyamoto S; Mabuchi H; Takeda R
    Nihon Ronen Igakkai Zasshi; 1980 Nov; 17(6):618-23. PubMed ID: 7206300
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipoprotein(a) and familial hypercholesterolemia: Partners in crime in heritable hyperlipidemia.
    Kamstrup PR
    Atherosclerosis; 2023 Jan; 365():25-26. PubMed ID: 36642659
    [No Abstract]   [Full Text] [Related]  

  • 10. ESSENTIAL FAMILIAL HYPERCHOLESTEROLEMIA AND XANTHOMATOUS HEART DISEASE.
    SANCHEZ-VALENTIN R; GARCIA-PALMIERI MR
    Bol Asoc Med P R; 1963 Sep; 55():359-71. PubMed ID: 14051425
    [No Abstract]   [Full Text] [Related]  

  • 11. Essential familial hypercholesterolemia.
    WILKINSON CF; HAND EA; FLIEGELMAN MT
    Ann Intern Med; 1948 Oct; 29(4):671-86. PubMed ID: 18890269
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypercholesterolemia Among Premature Infarcts: Time to Start the Clock of Familial Hypercholesterolemia Assessment.
    Hovingh GK; Reeskamp LF; Ray KK
    J Am Coll Cardiol; 2019 May; 73(19):2451-2453. PubMed ID: 31097166
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple Xanthoma Tuberosum in a Case of Familial Homozygous Hypercholesterolemia.
    Singhania P; Biswas P; Dhar A
    J ASEAN Fed Endocr Soc; 2023; 38(1):134-135. PubMed ID: 37252422
    [No Abstract]   [Full Text] [Related]  

  • 14. Migratory polyarthritis in familial hypercholesterolemia (type IIa hyperlipoproteinemia).
    Chakraborty PP; Mukhopadhyay S; Achar A; Pal M; Mondal PC
    Indian J Pediatr; 2010 Mar; 77(3):329-31. PubMed ID: 20140769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monogenic, polygenic, and oligogenic familial hypercholesterolemia.
    Tada H; Nohara A; Kawashiri MA
    Curr Opin Lipidol; 2019 Aug; 30(4):300-306. PubMed ID: 31290811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reply: Familial Hypercholesterolemia Causes Sudden Death.
    Webster G; Olson R; Balmert LC; Cherny S; George AL
    J Am Coll Cardiol; 2019 Dec; 74(23):2952-2953. PubMed ID: 31806143
    [No Abstract]   [Full Text] [Related]  

  • 17. The Independent Malignity of Familial Hypercholesterolemia.
    Mascitelli L; Goldstein MR
    J Am Coll Cardiol; 2017 Feb; 69(6):753-754. PubMed ID: 28183515
    [No Abstract]   [Full Text] [Related]  

  • 18. [ESSENTIAL XANTHOMATOUS HYPERCHOLESTEREMIA].
    BEAUMONT JL; BEAUMONT V; CLAUDE JR
    Acta Cardiol; 1965; 20():45-59. PubMed ID: 14303245
    [No Abstract]   [Full Text] [Related]  

  • 19. [CHEMICAL COMPOSITION OF SF O-12 LIPOPROTEINS IN FAMILIAL XANTHOMATOUS HYPERCHOLESTEREMIA].
    BEAUMONT JL; SWYNGHEDAUW B; BEAUMONT V
    Rev Fr Etud Clin Biol; 1965 Feb; 10():221-4. PubMed ID: 14309899
    [No Abstract]   [Full Text] [Related]  

  • 20. A systematic review of current studies in patients with familial hypercholesterolemia by use of national familial hypercholesterolemia registries.
    Mundal L; Retterstøl K
    Curr Opin Lipidol; 2016 Aug; 27(4):388-97. PubMed ID: 27070076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.